Company: BBVXF
Filing Date: 2025-02-14
Form Type: 6-K
Source: 0001193125-25-027348
Chunk: 14

Company: BANCO BILBAO VIZCAYA ARGENTARIA, S.A.
Filing Date: 2025-02-14
Form: 6-K
Chunk 14
---
 applicable legislation; (ii) the acquisition price per share may not be lower than the nominal value of the share, and must be under 10% higher than the share price or any other price associated with the shares at the time that they are acquired. It also authorized that the shares acquired through this authorization be partially or totally set aside for delivery to employees or directors of BBVA or its subsidiaries, either directly or as a result of them exercising any option rights, vesting powers in the Board, in the broadest terms, to exercise the aforementioned authorization. (A.10) (C.1.9) Further to the authority delegated by the BBVA General Meeting of March 18, 2022, under item 6 on the agenda, BBVA announced on March 1, 2024 that its Board of Directors had resolved, once it had received the mandatory authorization from the European Central Bank (“ECB”), to carry out a program to buy back its own shares, in accordance with the provisions of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse, and Commission Delegated Regulation (EU) No 2016/1052 of 8 March 2016 supplementing the previous regulation with regard to regulatory technical standards for the conditions applicable to buy-backprograms and stabilization measures (together, the “Regulations”), for a maximum combined amount of €781 million, for the purpose of reducing BBVA’s share capital. This program began on March 4, 2024 and ended on April 9, 2024, upon reaching the maximum monetary amount of€781 million and having acquired 74,654,915 treasury shares, representing approximately 1.28% of BBVA’s share capital at that date. 3.6. Agreements on share capital (A.10) The BBVA General Meeting held on April 20, 2021, under item 5 on the agenda, passed a resolution to delegate to the Board the power to issue securities convertible into newly issued BBVA shares, for a term of 5 years, in order to meet regulatory requirements for their eligibility as capital instruments, in accordance with capital adequacy regulations and other applicable law, for a maximum overall amount of €8,000,000,000, or its equivalent in another currency, with the ability to determine: (i) the terms, characteristics and conditions of issuances; (ii) the form, timing, assumptions